66 results
DEFM14A
IMGN
Immunogen, Inc.
2 Jan 24
Proxy related to merger
4:26pm
respects with (i) the applicable provisions of Sarbanes-Oxley and the Exchange Act and (ii) the applicable listing and corporate governance rules
PREM14A
IMGN
Immunogen, Inc.
21 Dec 23
Preliminary proxy related to merger
4:52pm
) the applicable listing and corporate governance rules and regulations of Nasdaq.
(f) This Section 3.10 does not apply to Taxes, which are addressed
DEFA14A
EX-2.1
IMGN
Immunogen, Inc.
30 Nov 23
Additional proxy soliciting materials
4:07pm
) the applicable listing and corporate governance rules and regulations of Nasdaq.
(f) This Section 3.10 does not apply to Taxes, which are addressed
8-K
EX-2.1
IMGN
Immunogen, Inc.
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHEREĀ® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
4:05pm
) the applicable listing and corporate governance rules and regulations of Nasdaq.
(f) This Section 3.10 does not apply to Taxes, which are addressed
8-K
7ox3r2svv1kqe7bmrb
23 Sep 21
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
icjljnzz1yf
2 Jul 20
Departure of Directors or Certain Officers
4:16pm